GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma

NCT05913388 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma
Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: GB1211
DRUG: Pembrolizumab
DRUG: Placebo

Sponsor

Providence Health & Services

Collaborators

[object Object]
[object Object]
[object Object]